Clinical Trial

iExposure Intervention for Social Anxiety

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 9, 2026 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Social anxiety (SA) is a highly prevalent mental health concern, thought to disproportionately affect youth with recent international estimates of more than 30% of individuals reporting clinically elevated symptoms. Despite the prevalence of SA, as few as one in five individuals receive care, due to limited access to evidence-based treatments. Additionally there has been a notable increase in social anxiety since the start of the COVID-19 pandemic. This proposal will use iExposure to develop a personalized mechanism-focused approach to optimizing treatment response for individuals with social anxiety by testing standard iExposure against two augmentations that incorporate distinct attention mechanisms (attention guidance and attention control).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-05-07; most recent amendment 2026-03-05.
Status change: Recruiting → Active, Not Recruiting 2026-02-20
Status change: Not Yet Recruiting → Recruiting 2024-07-01
Trial Details
NCT Number NCT06409247
Lead Sponsor Palo Alto University
Conditions Social Anxiety
Enrollment 390 participants
Start Date 2024-07-01
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-09